GliSODin® abrogates asthma features and reduces CD4+ T-cell polarization and reactivation. Taken together, these data suggest that GliSODin® could be used for the management of asthma symptoms.
The results showed that enteral administration of CME-gliadin of 1 IU/day and 5 IU/day
significantly increased SOD levels based on examination after 14 and 28 days. Also, it significantly decreased
MDA (p < 0.001), TNF-α (p < 0.001), and lactate levels in rats induced by sepsis
The use of SOD as antioxidants is effective in accelerating symptom relief for children with asthma and house dust mite allergy receiving house dust mite immunotherapy.
Antioxidant supplementation resulted in an increase in SOD levels, confirming the oral bioavailability of the compound in FIV-infected cats.
Patients with acquired immunodeficiency syndrome (AIDS) present a variety of pathologic alterations that are related to oxidative stress.
Authors: Rahman H., Rocco R., Tabassum V. View publication Journal: Center for Family of Health of St. Mary’s, Hoboken NJ. Contributed by Millennium Biotechnologies, Inc Date: 2004 Abstract View publication
In this study, we have shown that this combination also primed and polarized the mouse Th1/Th2 immune response by affecting: (a) the production of IFN-γ and IL-4 cytokines from primed spleen cells after stimulation with Con-A and (b) the isotypes of antibody response (IgG, IgE and IgA).
